Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by de Jonge, P. Search for Related Content PubMed Citation Articles by de Jonge, P. Depression Syndromes Secondary to General Medical Disorders Behavior Therapy Cognitive Therapy Antidepressants Related Article

Nonresponse to Treatment for Depression Following Myocardial Infarction: Association With Subsequent Cardiac Events

The MIND-IT Investigators

OBJECTIVE: Depression following myocardial infarction is associated with an increased risk of cardiac events, but attempts to alter cardiovascular prognosis by providing antidepressive treatment have not been successful. This may be because of the limited effects of antidepressive treatment on depression itself. The authors assessed whether nonresponse to treatment of post-myocardial infarction depression is associated with new cardiac events. METHOD: The authors made a subgroup analysis of a multicenter randomized, clinical trial on the effects of antidepressant treatment for post-myocardial infarction depression. Patients were enrolled in double-blind, placebo-controlled treatment with mirtazapine (30 mg/day) and, in the case of insufficient treatment response after 8 weeks, open treatment with citalopram. Patients were classified as responders to antidepressants (at least 50% reduction in Hamilton Depression Rating scale [HAM-D] score or HAM-D score <9 at 24 weeks) (N=43) or as nonresponders (N=27) and compared to untreated control subjects (N=98) on cardiac events (cardiac mortality or cardiac-related hospital admission) after 24 weeks post-random assignment and within 18 months after index infarction. RESULTS: The event rate was 25.6% among nonresponders, 11.2% among untreated control subjects, and 7.4% among responders. In relation to untreated comparison subjects, nonresponders had a hazard ratio of 2.66 for new cardiovascular events, which remained after the authors controlled for potential confounders (hazard ratio=2.92). CONCLUSIONS: This study provides further preliminary evidence that nonresponse to treatment of post-myocardial infarction depression may be associated with cardiac events. Efforts should be dedicated to developing more effective treatments for depressed patients with myocardial infarction.

Related Article:

In This Issue
Am J Psychiatry 2007 164: A36. [Full Text] [PDF]

This article has been cited by other articles:

				A. H. Glassman, J. T. Bigger Jr, and M. Gaffney Psychiatric Characteristics Associated With Long-term Mortality Among 361 Patients Having an Acute Coronary Syndrome and Major Depression: Seven-Year Follow-up of SADHART Participants Arch Gen Psychiatry, September 1, 2009; 66(9): 1022 - 1029. [Abstract] [Full Text] [PDF]

				M. ZUIDERSMA and P. de JONGE The Effects of Treatment-Resistant Depression and First-Ever Depression on Mortality Following Acute Coronary Syndrome: Interactive or Independent? Am J Psychiatry, July 1, 2009; 166(7): 828 - 829. [Full Text] [PDF]

				S. E. Linke, T. Rutledge, B. D. Johnson, V. Vaccarino, V. Bittner, C. E. Cornell, W. Eteiba, D. S. Sheps, D. S. Krantz, S. Parashar, et al. Depressive Symptom Dimensions and Cardiovascular Prognosis Among Women With Suspected Myocardial Ischemia: A Report From the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation Arch Gen Psychiatry, May 1, 2009; 66(5): 499 - 507. [Abstract] [Full Text] [PDF]

				R. M. Carney and K. E. Freedland Treatment-Resistant Depression and Mortality After Acute Coronary Syndrome Am J Psychiatry, April 1, 2009; 166(4): 410 - 417. [Abstract] [Full Text] [PDF]

				L. POZUELO, G. TESAR, J. ZHANG, M. PENN, K. FRANCO, and W. JIANG Depression and heart disease: What do we know, and where are we headed? Cleveland Clinic Journal of Medicine, January 1, 2009; 76(1): 59 - 70. [Abstract] [Full Text] [PDF]

				M. A. Whooley, P. de Jonge, E. Vittinghoff, C. Otte, R. Moos, R. M. Carney, S. Ali, S. Dowray, B. Na, M. D. Feldman, et al. Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease JAMA, November 26, 2008; 300(20): 2379 - 2388. [Abstract] [Full Text] [PDF]

				V. Culic Psychology, cardiology, and gender Eur. Heart J., October 2, 2008; 29(20): 2577 - 2577. [Full Text] [PDF]

				P. de Jonge and J. Ormel Heterogeneity of Patients With Coronary Artery Disease and Distress and the Need to Identify Relevant Subtypes Arch Gen Psychiatry, July 1, 2008; 65(7): 851 - 852. [Full Text] [PDF]

				C. E. Angermann, G. Gelbrich, S. Stork, A. Fallgatter, J. Deckert, H. Faller, G. Ertl, and on behalf of the MOOD-HF Investigators Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF) Eur J Heart Fail, December 1, 2007; 9(12): 1212 - 1222. [Abstract] [Full Text] [PDF]

				P. de Jonge, J. P. van Melle, and J. Ormel Authors' reply: The British Journal of Psychiatry, November 1, 2007; 191(5): 456 - 457. [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 2007 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us